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Metazoan replication-dependent histone mRNAs are the only eukaryotic mRNAs that are not polyadeny-
lated. The cleavage of histone pre-mRNA to form the unique 3 end requires the U7 snRNP and the stem-loop
binding protein (SLBP) that binds the 3 end of histone mRNA. U7 snRNP contains three novel proteins,
Lsm10 and Lsm11, which are part of the core U7 Sm complex, and ZFP100, a Zn finger protein that helps
stabilize binding of the U7 snRNP to the histone pre-mRNA by interacting with the SLBP/pre-mRNA complex.
Using a reporter gene that encodes a green fluorescent protein mRNA ending in a histone 3 end and mimics
histone gene expression, we demonstrate that ZFP100 is the limiting factor for histone pre-mRNA processing
in vivo. The overexpression of Lsm10 and Lsm11 increases the cellular levels of U7 snRNP but has no effect
on histone pre-mRNA processing, while increasing the amount of ZFP100 increases histone pre-mRNA
processing but has no effect on U7 snRNP levels. We also show that knocking down the known components of
U7 snRNP by RNA interference results in a reduction in cell growth and an unsuspected cell cycle arrest in
early G1, suggesting that active U7 snRNP is necessary to allow progression through G1 phase to S phase.
The synthesis of histone proteins is tightly coupled to DNA
replication to ensure that the histone protein production will
be sufficient to assemble newly replicated DNA into chroma-
tin. In metazoans, the temporal control over histone protein
production is achieved primarily through the modulation of the
replication-dependent histone mRNA levels (26, 27). The reg-
ulation of histone mRNA occurs at multiple steps, including an
increase in the rate of histone gene transcription at the begin-
ning of S phase as well as a decrease in the half-life of histone
mRNA at the end of S phase. However, the primary engine
that drives the levels of histone mRNA to an S-phase level
35-fold higher than that in G1 or G2 phase is an increase in the
efficiency of histone pre-mRNA processing during S phase (19,
46). Histone mRNAs end in a conserved stem-loop (SL) struc-
ture rather than a poly(A) tail. The 3 end is a critical element
for multiple steps in histone mRNA metabolism, including the
translation (12, 32) and control of the degradation of the
mRNA (29). The SL is not only required for each of these
steps in mRNA metabolism but also sufficient to confer cell
cycle regulation on a heterologous mRNA (19, 35).
The 3 end of histone mRNA is formed by an endonucleolytic
cleavage of the nascent histone pre-mRNA between the SL
bound to SL binding protein (SLBP) and a second cis element
called the histone downstream element (HDE) (Fig. 1) (13, 28).
The HDE interacts with U7 snRNP by base pairing with the 5
end of the U7 snRNA (4, 6, 33). The U7 snRNP is present at very
low levels (500 to 1,000 molecules/HeLa cell compared to 5  105
to 5  106 molecules/cell for spliceosomal snRNPs), contains a
noncanonical Sm binding site (18), and is known to function
only in the processing of histone pre-mRNAs. The U7 snRNP
contains five Sm proteins common to the spliceosomal
snRNPs; however, in lieu of Sm D1 and D2, it contains two
Sm-like proteins, Lsm10 and Lsm11 (30, 31). In addition, it
contains the ZFP100 protein, which interacts with the
SLBP/SL complex (7) and Lsm11 (30, 40). Cleavage requires a
factor that contains CPSF-73 (9) and several other factors
required for polyadenylation (22). SLBP levels oscillate
throughout the cell cycle; SLBP is expressed just prior to entry
into S phase, allowing the synthesis of the histone mRNA, and
SLBP is degraded at the end of S phase (43, 46).
Here we report that ZFP100 is a limiting component for
histone pre-mRNA processing in mammalian cells and that
increased expression of ZFP100, but not of the U7 snRNP
proteins Lsm10 and Lsm11 (30, 31), stimulates the expression
of a novel green fluorescent protein (GFP)-based reporter
containing the cis-acting sequences necessary for histone
mRNA production. We also demonstrate that RNA interfer-
ence (RNAi)-mediated knockdown of ZFP100 leads to a cell
cycle arrest early in G1 phase and that knockdown of the U7
snRNP proteins Lsm10 and Lsm11 also results in an accumu-
lation of cells in early G1 phase. This phenotype contrasts with
the delayed progression through S phase that results from
SLBP knockdown (38, 45) and suggests that the cell monitors
the availability of active U7 snRNP prior to committing to
enter S phase.
MATERIALS AND METHODS
Plasmid construction. The GFP-SL reporter clone was constructed by cloning
the H2A-614 promoter in place of the cytomegalovirus (CMV) promoter of the
pEGFPd4-N1 plasmid (Clontech, Mountain View, CA) and replacing the simian
virus 40 poly(A) site with the H2A-614 SL and HDE. myc-tagged ZFP100 clones
were made by the insertion of PCR-generated ZFP100 fragments cloned into the
KpnI and ApaI sites of pcDNA4-TO-HisB (Invitrogen, Carlsbad, CA). All clones
were sequenced, and the sequences of all primers are available upon request.
Cell culture and transfection. HEK 293T, HeLa, and U2OS cells were cul-
tured using standard techniques with Dulbecco’s modified Eagle’s low-glucose
medium supplemented with 10% fetal bovine serum. 293T cells were transfected
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with plasmid using either Lipofectamine or Lipofectamine 2000 according to the
manufacturer’s protocol (Invitrogen). Short interfering RNA (siRNA) transfec-
tions were performed using a modified version of a two-hit protocol previously
published elsewhere (39).
Immunoblotting. 293T or HeLa cells transfected with myc-tagged ZFP100
were harvested by incubation with hot (approximately 80°C) sodium dodecyl
sulfate (SDS) loading buffer, followed by five passes through a 22-gauge needle.
Lysates were resolved by SDS-polyacrylamide gel electrophoresis and blotted
with anti-myc monoclonal antibody (Invitrogen) at a dilution of 1:1,000. Lysates
from U2OS cells were prepared by incubation with NP-40 lysis buffer (100 mM
Tris [pH 8.3], 0.5% NP-40, 100 mM NaCl, 100 mM phenylmethylsulfonyl fluo-
ride). Blots were probed with a 1:1,000 dilution of polyclonal antiserum raised
against SLBP (41).
Northern blot analysis. Approximately 2 g of total cell RNA was resolved on
a 1.5% agarose gel containing both formaldehyde and MOPS (morpholinepro-
panesulfonic acid), followed by electrophoretic transfer to a HybondN nitrocel-
lulose membrane (Amersham Biosciences, Piscataway, NJ). The membrane was
UV cross-linked and probed with a random-labeled PCR probe to H2A-614
open reading frame (ORF), 7SK, or GFP ORF overnight at 60°C, according to
the instructions for the QuikHyb blotting agent (Stratagene, La Jolla, CA). U7
snRNA was detected as previously described (10).
RT-PCR. Total cellular RNA was isolated using TRIzol reagent. RNA was
subject to reverse transcription (RT) using the manufacturer’s protocols (New
England Biolabs, Natick, MA) using random hexamer primers. Approximately
1/10 of the RT reaction was used as a template for PCR. The primers used were
5-GAGACCAAGAACTCTCCTCTG-3 and 5-TCGCCTAGCAAACTATCT
AAC-3 for ZFP100, 5-AGACCCGAGAGCTTTACCACT-3 and 5-AGGTG
TCTTGGGACTTCTTTA-3 for SLBP, 5-GAATACGCATACTTTAGAAA
T-3 and 5-CTCATTAGCTGTCCTGCATGC-3 for h3Exo, 5-TGCGGGAT
GAGAGCGTGGCCC-3 and 5-TGGATAATCTGCAGCTGCTGC-3 for
Lsm10, and 5-GTGAACTCCATCGCTGTATC-3 and 5-ATGCTTTGCCTA
GGACAGGT-3 for Lsm11. Simultaneous PCRs for SLBP and 3hExo were
carried out for 27 cycles (see Fig. 5C, left panels), simultaneous PCRs for
ZFP100 and 3hExo were carried out for 35 cycles (see Fig. 5C, right panels), and
the same RT was subject to PCR for either SLBP, h3Exo, or Lsm10/11 (see Fig.
6B and D). PCRs were removed at 27 cycles for SLBP, 35 cycles for h3Exo, and
36 cycles for Lsm11, and Lsm10 was removed at 42 cycles. In all cases, multiple
cycle numbers were analyzed to ensure a linear range was analyzed, and in no
cases were there products in the absence of reverse transcriptase.
Cell cycle analysis and fluorescence-activated cell sorter (FACS) analysis.
Two days following the second siRNA transfection, U2OS cells were harvested
using trypsin and fixed in 70% ethanol at 80°C. Cell cycle analysis was carried
out as previously described (38). 293T cells analyzed for GFP fluorescence were
harvested using trypsin and then added to 37% formaldehyde to achieve a final
concentration of 0.5%. Cell fluorescence was quantified using a FACScan ma-
chine, and the data were analyzed using Summit.
RESULTS
The only processing reaction necessary to form mature his-
tone mRNA is an endonucleolytic cleavage of the histone
pre-mRNA to form the 3 end of histone mRNA. There are
three known factors required for processing diagrammed in
Fig. 1: SLBP, which binds the stem loop, U7 snRNP, which
base pairs with the HDE, and a cleavage factor that contains
CPSF-73 (9) and several other factors required for polyade-
nylation (22). Here we demonstrate that ZFP100, a U7 snRNP
protein that interacts with the SLBP/pre-mRNA complex (7),
is a limiting factor for histone pre-mRNA processing and is
required for entry into S phase.
A GFP histone stem-loop reporter gene. To readily visualize
the effects on histone mRNA expression, we constructed a
reporter gene encoding destabilized enhanced green fluores-
cent protein (EGFP) (4-h half-life) (23) to visualize and quan-
tify the amount of expression of a gene encoding a histone-like
mRNA within a mammalian cell. The GFP-SL gene contains a
histone promoter, the destabilized GFP open reading frame,
and a histone 3 end located at the same position relative to the
stop codon as in histone mRNAs (Fig. 2A). As a control, we
used a GFP-pA gene that contains a CMV promoter, a GFP
open reading frame, and the simian virus 40 early mRNA
polyadenylation signal (Fig. 2A). Wild-type GFP is quite stable
in cells having a half-life of about 26 h (5), whereas the desta-
bilized GFP (half-life, 4 h) is advantageous as it provides a
rapidly changing readout since the levels of histone mRNAs
are rapidly regulated during the cell cycle (19).
To establish that the GFP-SL reporter mimicked endoge-
nous histone mRNAs, we tested two criteria characteristic of
histone mRNA: restriction of expression to S phase and deg-
radation of histone mRNAs when DNA replication is inhib-
ited. To determine whether the GFP-SL reporter was ex-
pressed primarily during S phase, we used two different
techniques to mark S-phase cells: cotransfection of cells with a
DsRed-SLBP fusion protein or labeling with bromodeoxyuri-
dine (BrdU). SLBP is present in only S-phase cells and is
rapidly degraded at the end of S phase (11, 43). We cotrans-
fected either the GFP-SL reporter or the GFP-pA reporter,
together with a gene expressing the DsRed-SLBP fusion pro-
tein into 293T cells, and assayed the expression using fluores-
cence microscopy (Fig. 2A and B, upper panels). The GFP-pA
reporter was expressed efficiently, exhibiting high fluorescence
in a large fraction of cells (Fig. 2A). The degree of expression
was relatively constant from cell to cell. The GFP-pA reporter
was highly expressed in many cells that were not expressing
DsRed-SLBP (Fig. 2A, top row), consistent with this reporter
not being cell cycle regulated. The GFP-SL reporter, in con-
trast, was expressed in far fewer cells. Importantly, all the cells
expressing the DsRed-SLBP also expressed the GFP-SL re-
porter (Fig. 2B, top row). There was more-variable intensity of
the GFP-SL reporter among different S-phase cells. This vari-
ability is likely due to the amount of time these cells have been
in S phase. A fraction of the cells expressed the GFP-SL
reporter but not DsRed-SLBP, and these cells are likely those
that recently completed S phase and have entered G2. The
destabilized GFP used in these experiments has a 4-h half-life,
and thus, the protein will persist into G2 (with expression
FIG. 1. Histone pre-mRNA processing. The two cis elements re-
quired for processing in the histone pre-mRNA are the SL and the
HDE, which are bound by the SLBP and U7 snRNP, respectively. The
three known unique components of the U7 snRNP, Lsm10, Lsm11,
and ZFP100, are shown. A cleavage factor containing CPSF-73 and
symplekin as well as other polypeptides is then recruited to catalyze the
cleavage (9, 22). nt, nucleotide.
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decreasing), whereas the DsRed-SLBP fusion protein is de-
stroyed at the end of S phase.
To further confirm that the GFP-SL reporter was selectively
expressed in S-phase cells, we also transfected either the
GFP-pA or the GFP-SL reporter into 293T cells and then
pulsed them with BrdU for 15 min. In the case of the GFP-pA
reporter, many cells that were positive for the reporter were
negative for BrdU incorporation (Fig. 2A, lower panel),
whereas cells that were positive for the GFP-SL reporter were,
in most cases, BrdU positive (Fig. 2B, lower panel). These two
assays both indicate that the GFP-SL reporter expression is
specifically enriched in S-phase cells.
Histone mRNAs are rapidly degraded when cells are treated
with DNA synthesis inhibitors, such as hydroxyurea (HU) (17),
and degradation is directed by the stem-loop (29). We treated
cells transfected with each reporter with HU. Eight hours after
HU treatment, there was a marked decrease in the fluores-
cence of the GFP-SL reporter as visualized by fluorescence
microscopy (Fig. 2C, left panels), whereas there was no detect-
able change in the intensity of fluorescence from the GFP-pA
reporter. To quantify the expression of the destabilized green
fluorescent protein (dGFP), we used FACS analysis. This gives
both a readout of the percentage of cells expressing dGFP and
the average intensity of expression in individual cells. After
HU treatment, there was a fivefold decrease in the average
GFP intensity as well as a sixfold decrease in the percentage of
cells residing within the gated value of GFP in GFP-SL report-
er-transfected cells (Fig. 2C). There was no significant differ-
ence in the intensity of GFP fluorescence or in the percentage
of cells residing within the gated value of GFP in the GFP-pA
FIG. 2. The GFP-SL reporter gene mimics the expression of histone mRNA. (A) A schematic of the GFP-pA reporter (top). The top row of
images is fluorescence microscopy of 293T cells cotransfected with the GFP-pA reporter, together with a plasmid expressing a DsRed-SLBP fusion
protein. The white arrows indicate cells that express GFP and not DsRed-SLBP. The second row of images shows confocal microscopy of 293T
cells transfected with the GFP-pA reporter and labeled with BrdU. The white arrows indicate cells that express GFP, and the yellow arrows denote
BrdU-positive nuclei. (B) A schematic of the GFP-SL reporter (top). The top row of images is fluorescence microscopy of 293T cells cotransfected
with the GFP-SL reporter, together with a plasmid expressing a DsRed-SLBP fusion protein. The white arrows indicate cells that express GFP and
are also expressing DsRed-SLBP. The second row of images is confocal microscopy of 293T cells transfected with the GFP-SL reporter and labeled
with BrdU. The white arrows indicate cells that express GFP, and the yellow arrows denote BrdU-positive nuclei. (C) 293T cells were transfected
with the indicated reporter, and then 5 mM HU was added for 8 h. The left panels are the bright-field and fluorescence images. The FACS analysis
of the cells detecting the amount of GFP fluorescence is shown in the middle panel, with the percentage of cells expressing a gated value of GFP
denoted. The results were quantified by measuring total fluorescence. The x axis represents relative GFP units as assayed by the FACScan, and
cell number is on the y axis. The percentage of cells expressing GFP and not treated with HU was set at 100%, and the others were quantified as
a percentage of that value. The error bars on the graph on the right represent the standard deviations from three independent experiments. ,
with; , without. (D) The levels of the reporter mRNA and the endogenous histone H2a mRNA were determined by Northern blotting (top) of
the cells analyzed in panel C. At the bottom is an analysis of total RNA resolved by agarose gel electrophoresis and detected by staining with
ethidium bromide. , with; , without.
6704 WAGNER AND MARZLUFF MOL. CELL. BIOL.
reporter-transfected cells with and without HU treatment (Fig.
2C, right panel). Similarly, the RNA from the GFP-SL re-
porter was downregulated in response to hydroxyurea treat-
ment to the same extent as was the endogenous histone H2A
mRNA (Fig. 2D, lane 1 versus lane 2), whereas the GFP-
pA-derived mRNA was unaffected (Fig. 2D, lane 3 versus
lane 4). The combination of an S-phase enrichment of cells
expressing the GFP-SL reporter coupled with the sensitivity
to HU treatment allowed us to conclude that this reporter
recapitulates endogenous histone mRNA expression in
293T cells.
Expression of SLBP or ZFP100 increases expression of the
dGFP reporter. Increasing the concentration of any factors
limiting for histone mRNA expression, which may include ei-
ther or both 3 end processing or translation, will likely in-
crease the amount of GFP expressed from the GFP-SL gene.
To test which factors might be limiting for expression, we
cotransfected GFP-SL or GFP-pA, together with hemaggluti-
nin-SLBP, myc-ZFP100, myc-Lsm10, and/or myc-Lsm11 or
with myc-LacZ as a control (Fig. 3 and 4). The transfection of
either SLBP or ZFP100 increased the intensity of fluorescence
but gave only a slight increase in the number of fluorescing
cells, while the transfection of myc-LacZ had no effect (Fig.
3A, left panels). This increase in fluorescence was not caused
by an increase in the number of S-phase cells since cell cycle
analysis revealed there was no significant change in cell cycle
distribution (Fig. 3B). A quantification of this increase by
FACS analysis demonstrated that the expression of SLBP in-
creased the intensity of fluorescence threefold, whereas the
expression of ZFP100 increased the fluorescence nearly four-
fold (Fig. 3A, right panel). Neither SLBP nor ZFP100 had any
effect on the expression of the GFP-pA reporter (Fig. 3A, right
panel). The increase in fluorescence was dependent on the
amount of SLBP or ZFP100 introduced (Fig. 3C). Note that
FIG. 3. Expression of ZFP100 or SLBP stimulates expression of the GFP-SL reporter. (A) The left panel represents brightfield and fluores-
cence images of the different cells transfected with H2A-dGFP-SL and the myc-tagged lacZ, SLBP, or ZFP100 for 24 h, followed by the
transfection of the GFP-SL reporter. The graph on the right is the quantification of FACS analysis of the cells transfected with either GFP-pA
or GFP-SL cells, together with () lacZ, SLBP, or ZFP100. Error bars represent standard deviations of a triplicate set of transfections. (B) Cells
transfected with () myc-tagged lacZ, SLBP, or ZFP100 for 48 h were analyzed for cell cycle distribution by flow cytometry. (C) Cells were
transfected with plasmids encoding either SLBP, ZFP100, or LacZ as a control at the doses labeled at the bottom of the graph. Twenty-four hours
later, 2 g of either GFP-SL or GFP-pA reporter plasmid was transfected into each well. The next day, cells were harvested and analyzed by FACS
analysis to determine relative fluorescence level. The data are presented as severalfold increases in fluorescence over cells transfected with LacZ,
and error bars are representative of a triplicate set of transfections. A transfection of more than 1 g of ZFP100 plasmid was toxic to the cells (40).
(D) Total cell RNA (5 g) from a representative experiment similar to that in panel A with the cells transfected (trans.) with the GFP-SL gene
was analyzed using an S1 protection assay that can detect both transcripts that end at the stem-loop and readthrough transcripts. Probe design is
depicted in the schematic below, with the anticipated protected fragments labeled. nt, nucleotide. The position of the probe on the gel is indicated.
Protected fragments longer than the stem-loop (arrowheads at right) represent readthrough transcripts. Lanes 1 and 5 are cells transfected with
LacZ, lanes 2 to 4 are cells transfected with increasing amounts of ZFP100 plasmid, and lanes 6 to 8 are cells transfected with increasing amounts
of SLBP plasmid. The amounts of plasmid are indicated above each lane.
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much lower levels of ZFP100 plasmid than SLBP plasmid were
required to stimulate expression of the GFP-SL reporter, con-
sistent with the low abundance of ZFP100 and the stoichio-
metric requirement for SLBP.
The increase in GFP-SL expression in response to ZFP100
transfection is reflected in an increase in the properly pro-
cessed GFP-SL reporter mRNA ending at the 3 end of the
histone mRNA (Fig. 3D) (40). The expression of a different
GFP-SL reporter driven by the CMV promoter was also stim-
ulated by myc-ZFP100 to a similar extent (not shown), consis-
tent with a stimulation of histone pre-mRNA processing. Thus,
while increased GFP expression could result from increases in
mRNA levels due to increased transcription or an increase in
mRNA half-life or from an increased rate of translation, the
stimulation observed by increased ZFP100 levels is most likely
due to an increase in histone pre-mRNA processing. The in-
teraction of ZFP100 with the U7 snRNP and its positive effect
on processing in Xenopus oocytes (7) as well as its stable
localization to Cajal bodies (40) strongly suggest a role in
processing and not transcription or translation.
To measure the reporter mRNA ending at the histone 3
end directly, we designed a probe to be used in an S1
protection assay that is complementary to a portion of the
GFP ORF, the SL, and HDE as well as some of the down-
stream sequence present in the plasmid. RNA was analyzed
from cells cotransfected with reporter and increasing
amounts of myc-ZFP100 or hemagglutinin-SLBP [both plas-
mids contain the CMV promoter and the bovine growth
hormone poly(A) signal] compared to the analysis of RNA
isolated from cells cotransfected with LacZ. Increasing the
expression of myc-ZFP100 led to a dose-dependent increase
in the level of processed GFP mRNA (Fig. 3D, lanes 1 to 4).
There are also longer mRNAs (Fig. 3D), which likely rep-
resent readthrough transcripts that might become polyade-
nylated and contribute to the background GFP expression in
cells not transfected with ZFP100. This selective and dose-
dependent increase in the level of processed GFP-SL mes-
sage in response to increasing amounts of ZFP100 strongly
supports the conclusion that the increase in GFP fluores-
cence as a result of the expression of ZFP100 reflects an
increase in the efficiency of processing.
In contrast, the effect of SLBP expression could be due to a
combination of stimulating processing, stabilizing the mRNA,
and enhancing mRNA translation, all steps which SLBP is
known to impact (26). The stimulation of GFP levels by SLBP
was as large as or larger than the stimulation by ZFP100 (Fig.
3C), although the increase in mRNA was lower, and there was
not a direct relationship between the amount of reporter
mRNA and GFP expression (Fig. 3D, lanes 5 to 8). This
suggests that there must also be an effect of SLBP on transla-
tion of the reporter mRNA, in addition to its effects on either
processing or stability or both.
Expression of Lsm10 or Lsm11 does not activate the re-
porter. ZFP100 interacts with the U7 snRNP through the di-
rect binding to the U7 snRNP protein Lsm11 (30) in a region
of the amino-terminal portion of Lsm11 (40). Thus, the in-
crease in activity of the reporter as a result of transfection of
ZFP100 could result from an increase in the amount of active
U7 snRNP. The assembly of U7 snRNP involves the incorpo-
ration of Lsm11 and Lsm10 into the U7 snRNP as a het-
erodimer (1). Normally, only a fraction of the U7 snRNA that
is transcribed is incorporated into U7 snRNP (18), suggesting
that incorporation of Lsm10 and Lsm11 is limiting for U7
snRNP formation. U7 snRNA that is not rapidly incorporated
into U7 snRNP is rapidly degraded (18).
We determined the effects of increasing expression of
Lsm10, Lsm11, and ZFP100 and combinations of these pro-
teins on U7 snRNA levels as well as on the expression of the
GFP-SL reporter. The expressions of the myc-tagged Lsm11,
Lsm10, and ZFP100 proteins were comparable (Fig. 4A).
However, the expression of Lsm11, Lsm10, or the two proteins
together had little impact on the activity of the reporter (Fig.
4B, lanes 2, 3, and 6), suggesting that these proteins were not
limiting for histone pre-mRNA processing. In support of this
notion, when we cotransfected all three proteins, Lsm10,
Lsm11, and ZFP100, this combination activated the expression
FIG. 4. Expression of Lsm10 and/or Lsm11 does not affect expression of the GFP-SL reporter. (A) Cells were transfected with myc-tagged
ZFP100 (lane 1), Lsm11 (lane 2), Lsm10 (lane 3), or combinations of ZFP100 and Lsm11 (lane 4), ZFP100 and Lsm10 (lane 5), Lsm10 and Lsm11
(lane 6) or all three proteins (lane 7). Extracts from equal amounts of cells were resolved by gel electrophoresis and transferred to nitrocellulose,
and the expressed proteins were detected with an anti-myc antibody. (B) The cells were also analyzed for GFP fluorescence (top). Cells
cotransfected with myc-lacZ, which did not affect GFP expression, were used as a control. Total cell RNA was isolated from the cells and resolved
by electrophoresis on polyacrylamide gels, and probed for U7 snRNA and 7SK RNA, or resolved by electrophoresis on agarose gels and probed
for histone H2A mRNA (bottom). Error bars indicate standard deviations.
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of the reporter to the same extent as did ZFP100 alone (Fig.
4B, lane 7). Cotransfection of ZFP100 with either Lsm10 or
Lsm11 resulted in a stimulation of expression of the reporter
which was lower than that observed with transfection of
ZFP100 alone (Fig. 4B, lanes 4 and 5). We interpret the re-
duction in ZFP100 stimulation with either Lsm10 or Lsm11
alone to be the result of a toxic effect of overexpressing only
one member of the Lsm11/Lsm10 heterodimer. Thus, the crit-
ical U7 snRNP protein required for stimulation of the expres-
sion of the GFP-SL reporter is ZFP100.
Expression of Lsm10 and Lsm11, but not ZFP100, increases
the amount of U7 snRNP. We measured the amount of U7
snRNA, histone H2A mRNA, and as a control, 7SK RNA
using Northern blot analysis of total RNA isolated from cells,
following the transfection of the U7 snRNP proteins (Fig. 4C).
None of the transfections resulted in any increase in the levels
of endogenous H2A mRNA (Fig. 4C), consistent with the lack
of effect on the cell cycle. Since the unique Sm sequence in the
U7 snRNA determines the amount of U7 snRNP that accu-
mulates in cells (18), it is likely that the levels of Lsm10 and
Lsm11 play a role in the amount of accumulation of U7
snRNP. The expression of either Lsm10 or Lsm11 alone or
together with ZFP100 increased U7 snRNA levels slightly
above control levels. However, the overexpression of Lsm10
and Lsm11 together resulted in a threefold increase in U7
snRNA (analyzed by PhosphorImager analysis and normalized
to the amount of 7SK RNA), although there was no effect on
expression of the reporter gene (Fig. 4B, lane 6). In contrast,
the overexpression of ZFP100 had no effect on U7 snRNA
levels (Fig. 4B, lane 2), even though it stimulated the expres-
sion of the reporter gene nearly fourfold. These results support
the notion that the Lsm10 and Lsm11 heterodimer is limiting
for U7 snRNA accumulation but that additional factors, in-
cluding ZFP100, are necessary for an active U7 snRNP parti-
cle. The expression of Lsm10, Lsm11, and ZFP100 together
stimulated U7 snRNA accumulation and resulted in maximal
expression of the GFP-SL reporter but was only slightly higher
than the expression of ZFP100 alone. Taken together, these
results support the conclusion that ZFP100, and not the total
amount of U7 snRNP, is a limiting component for histone
pre-mRNA processing and that the amount of ZFP100 is not
limiting for the accumulation of U7 snRNA.
siRNA-mediated downregulation of ZFP100 arrests cells in
early G1. Histone mRNAs are present in high concentrations
during only S phase and are necessary for the synthesis of the
histone proteins required for rapid assembly of chromatin on
newly replicated DNA. Knocking down any of the U7 snRNP
proteins should interfere with histone pre-mRNA processing,
resulting in a defect in histone protein synthesis. We expected
that defects in histone mRNA production might cause either
an arrest at the G1/S border or slowed S-phase progression. In
agreement with this expectation, we and others recently
showed that RNAi-mediated depletion of SLBP results in slow
progression through S phase (38, 45). In addition, interfering
with chromatin assembly also results in slowing progression
through S phase (44).
To test whether ZFP100 expression is required for cell cycle
progression, we depleted the protein using two siRNAs that
targeted unique regions of the ZFP100 open reading frame
(Z1 and Z2). ZFP100 is not detectable by Western blotting in
whole-cell lysates due to its low concentration. We therefore
monitored ZFP100 accumulation with and without siRNA
treatment by transfecting HeLa cells with a vector expressing a
myc-tagged ZFP100 (Fig. 5A). Neither the control siRNA (C2)
(Fig. 5A, lane 1) nor the S2 siRNA targeting SLBP (S2) (Fig.
5A, lane 5) had an effect on myc-ZFP100 expression. The two
siRNAs targeting the ZFP100 mRNA (Z1 and Z2) both re-
duced the expression of myc-ZFP100 (Fig. 5A, lanes 2 and 3),
as did the mixture of the two siRNAs (Fig. 5A, lane 4). None
of the siRNAs had any effect on polypyrimidine tract binding
protein expression used as a loading control. The Z1 siRNA
reduced the levels of myc-tagged ZFP by about 90%, and the
Z2 siRNA reduced the myc-tagged ZFP by more than 90%, as
quantified by comparison with a dilution of the C2-treated
lysate present on the same blot (Fig. 5A, lanes 6 to 9).
Knocking down ZFP100 in HeLa cells resulted in a reduced
growth rate, followed by cell death. We tested the effect of
knocking down ZFP100 in U2OS cells since these cells, unlike
HeLa cells, are more amenable to cell cycle analysis due to
their retention of intact p53 and pRb checkpoint systems. Un-
treated U2OS cells exhibited cell cycle profiles with about 50%
of the cells in G1 and 25% in S phase (Fig. 5B). Treatment of
these cells with siRNAs against ZFP100 blocked proliferation,
with a decrease in total cell number but not in cell viability (not
shown). Treated cell populations displayed dramatic increases
in the number of G1 cells (Fig. 5B) and decreases in S-phase
cells, while transfection with a control siRNA (C2) had no
effect. The transfection of the Z1/Z2 siRNA mixture resulted
in about 80% of the cells arresting in G1 phase (Fig. 5B).
U2OS cells transfected with the siRNA targeting SLBP also
exhibited a reduction in cell proliferation. However, in contrast
to the knockdown of U7 snRNP components, knockdown of
SLBP resulted in an increased percentage of cells in S phase
compared to the C2 siRNA (Fig. 5B, lower right panel), which
is in agreement with our previously reported results (38).
Using an RT-PCR assay, we demonstrated that the different
siRNAs specifically reduced their target endogenous mRNAs.
As an internal control, we determined the levels of endogenous
mRNA for 3hExo (8) in the same assay with SLBP mRNA
(Fig. 5C, lanes 1 to 3) or ZFP100 mRNA (Fig. 5C, lanes 4 to
6). 3hExo is an exonuclease associated with histone mRNA
(8) that serves as a nonspecific internal control and was not
affected by any of the siRNA transfected. The S2 siRNA re-
duced the levels of the endogenous SLBP mRNA (Fig. 5C,
lane 3), but it had no effect on the endogenous mRNA for
ZFP100 (Fig. 5C, lane 6). The Z1/Z2 siRNA depleted the
endogenous ZFP100 mRNA (Fig. 5C, lane 5) but had no effect
on SLBP mRNA (Fig. 5C, lane 2).
In order to determine whether the ZFP100-depleted cells
were arrested at the G1/S border or in G1 phase, we deter-
mined the levels of two cell cycle-regulated proteins, SLBP and
E2F1. SLBP is cell cycle regulated, and the protein accumu-
lates as cells approach entry into S phase (43). In particular,
SLBP is present at high levels in cells arrested either by aphi-
dicolin or by double-thymidine block at the G1/S border (43).
Although the amount of SLBP protein oscillates throughout
the cell cycle, the level of SLBP mRNA varies much less (43).
The cells with ZFP100 knocked down had a marked reduction
in the levels of SLBP protein (Fig. 5D, lanes 2 to 4), with the
amount of decrease with the Z1 and Z2 oligonucleotides cor-
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relating with the extent of G1 arrest (Fig. 5D). Thus, the
G1-arrested cells are likely arrested early in G1 phase, prior to
the increase of SLBP protein that occurs in late G1 (43).
Since SLBP and ZFP100 interact during histone pre-mRNA
processing (7), it was also possible that the SLBP levels were
directly coupled to ZFP100. E2F1 has an expression pattern
similar to that of SLBP during the cell cycle and also accumu-
lates in cells arrested at the G1/S border (J. Dong and W. F.
Marzluff, unpublished data). To further confirm that there was
indeed an arrest early in G1, we probed the same lysates for
expression of the E2F1 protein (Fig. 5E). The E2F1 protein
was not detected in ZFP100 siRNA-transfected cells; thus,
reducing the activity of U7 snRNP resulted in a cell cycle arrest
in G1 prior to the synthesis of proteins necessary for entry into
S phase.
siRNA-mediated downregulation of U7 snRNP components
Lsm11 or Lsm10 also arrests cells in early G1. The cell cycle
arrest resulting from ZFP100 depletion may result from de-
creased U7 snRNP activity, but it could also reflect a function
of ZFP100 distinct from its interaction with the U7 snRNP. To
FIG. 5. Knockdown of ZFP100 arrests U2OS cells in G1. (A) U2OS cells were treated with a control siRNA for 96 h (C2, lane 1), two different
siRNAs (Z1 and Z2, lanes 2 and 3) against ZFP100, a combination of those two siRNAs (Z1/Z2, lane 4) or siRNA against SLBP (S2, lane 5). The
cells were then transfected with a myc-tagged ZFP100. Lysates were prepared and resolved by SDS-gel electrophoresis, the myc-ZFP100 was
detected by Western blotting with anti-myc (top), and polypyrimidine tract binding protein (PTB) was analyzed as a loading control (bottom).
Lanes 6 to 9 show dilutions of the C2 lysate (100, 50, 20, and 10% of total) demonstrating that the myc-ZFP100 was knocked down at least 90%.
(B) Cell cycle analysis of U2OS cells 96 h after transfection with the control siRNA C2, the Z1 and Z2 siRNAs against ZFP, a combination of Z1
and Z2, or the S2 siRNA against SLBP. The percentage of cells in each cell cycle phase is shown. (C) Multiplex RT-PCR analysis of RNA isolated
from U2OS cells transfected with the respective siRNAs. The left panel contains amplified DNAs from primers to amplify SLBP mRNA and the
3hExo mRNA (8) as a control. The right panel contains amplified DNAs from primers to amplify ZFP100. (D) Western blot analysis of lysates
from U2OS cells transfected with either C2 siRNA (control), Z1, Z2, or a mixture of Z1 and Z2 or the S2 siRNA. Lysates were resolved by SDS-gel
electrophoresis and probed with an anti-SLBP polyclonal antibody. The asterisk denotes a cross-reacting band. (E and F) Lysates from U2OS cells
treated with the C2 (lane 1), Z1, and Z2 (lane 2) or S2 (lane 3) siRNAs were resolved by SDS-gel electrophoresis and probed with an anti-E2F1
antibody.
6708 WAGNER AND MARZLUFF MOL. CELL. BIOL.
rule out this possibility, we designed two sets of siRNAs tar-
geting either Lsm10 or Lsm11. Similar to ZFP100, the low
abundance of Lsm10 and Lsm11 precludes detection in whole-
cell lysates by Western blotting; thus, both sets of siRNAs were
cotransected with myc-tagged exogenous protein into HeLa
cells (Fig. 6A and D). Both siRNAs targeting Lsm11 reduced
the level of Lsm11 protein, with the L11-1 siRNA being more
potent than L11-2 (Fig. 6A), while the L10-2 siRNA was more
potent than the L10-1 siRNA (Fig. 6D). None of the siRNAs
had any effect on the levels of the CA150 nuclear protein, used
here as a loading control (15). We analyzed the effect of siRNA
transfection on the endogenous Lsm11 mRNA (Fig. 6B) or
endogenous Lsm10 mRNA (Fig. 6D) by using an RT-PCR
assay of total cellular RNA. The L11-1 siRNA reduced the
levels of the endogenous Lsm11 mRNA, while it did not have
any effect on either the endogenous SLBP mRNA or h3Exo
mRNA (Fig. 6B). The L10-2 siRNA also specifically decreased
the levels of endogenous Lsm10 mRNA, whereas it had no
effect on the levels of SLBP or h3Exo endogenous mRNA.
The transfection of any of these four siRNAs into U2OS
cells led to reduced proliferation and a reduction in the level of
SLBP that was comparable to, although not as dramatic as,
knocking down ZFP100 (Fig. 7A and C). Cell cycle analysis
demonstrated that cells transfected with the Z2 siRNA had 72
to 75% of cells in G1 phase compared to 45% in the control.
The knockdown of Lsm11 with either siRNA led to an inter-
mediate phenotype with 55 or 57% of cells in the G1 phase
(Fig. 7B), and the knockdown of Lsm10 resulted in 52 to 60%
of the cells in G1 phase (Fig. 7D). In each case, the more
potent siRNA (L11-1 and L10-2) resulted in the greatest ac-
cumulation of G1 cells. The reduced amount of cells in G1
arrest in the Lsm11 or Lsm10 knockdowns compared with that
in the ZFP100 knockdowns may reflect either a less efficient
knockdown or that ZFP100 is more critical to cell cycle pro-
gression. Evidence presented above demonstrates that ZFP is
a limiting factor for histone pre-mRNA processing. For exam-
ple, ZFP100 may be less stable than the core U7 snRNP com-
ponents. In addition, since our data here and elsewhere (40)
suggest that ZFP100 is critical for an active U7 snRNP, the
amount of active U7 snRNP may not have been reduced as
much by knocking down Lsm10 or Lsm11 as by knocking down
ZFP100.
DISCUSSION
Histone protein synthesis is tightly coupled to DNA repli-
cation to ensure the efficient replication of chromatin. In meta-
zoans, the histone mRNAs end in a unique 3 end which plays
a major role in coupling histone protein synthesis with DNA
replication. One component of the coupling is the rapid deg-
radation of histone mRNA when DNA replication is inhibited.
The degradation is mediated by the 3 end (29) and is inte-
FIG. 6. RNAi-mediated knockdown of the U7 snRNP proteins, Lsm11 and Lsm10. (A) U2OS cells were transfected for 96 h with a control
siRNA (C2, lane 1), two siRNAs against Lsm11 (11-1 and 11-2, lanes 2 and 3), a mixture of the two (11-1/2, lane 4), or an siRNA against SLBP
(S2, lane 5). Cells were then transfected with a plasmid expressing myc-tagged Lsm11. Lysates were prepared and the levels of myc-Lsm11
measured by Western blotting using an anti ()-myc antibody (bottom panel). As a control, the levels of CA150 (15) were analyzed (top) in the
same lysates. CA150; anti-CA150; myc; anti-myc. (B) RT-PCR analysis of RNA isolated from HeLa cells transfected with either control siRNA
(C2), siRNA targeting SLBP (S2), or siRNA targeting Lsm11 (11-1). The same RT reaction was subjected to PCR with primers for the 3hExo
mRNA (8) as a control, SLBP, or Lsm11. (C) U2OS cells were transfected with a control siRNA (C2, lane 1), two siRNAs against Lsm10 (10-1
and 10-2, lanes 2 and 3), a mixture of the two (10-1/2, lane 4), or an siRNA against SLBP (S2, lane 5). Cells were then transfected with a plasmid
expressing myc-tagged Lsm10. Lysates were prepared and the levels of myc-Lsm10 measured by Western blotting using an anti-myc antibody
(bottom panel). As a control the levels of CA150 were analyzed in the same lysates (top). CA150; anti-CA150; myc; anti-myc. (D) RT-PCR
analysis of RNA isolated from HeLa cells transfected with either control siRNA (C2), siRNA targeting SLBP (S2), or siRNA targeting Lsm10
(10-2). The same RT reaction was subjected to PCR with primers for the 3hExo mRNA (8) as a control, SLBP, or Lsm11.
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grated with the S-phase checkpoint, requiring the activation of
ATR (21). A second component that restricts histone
mRNA expression to S phase is regulation of the levels of
SLBP. SLBP accumulates to high levels during only S phase,
even though SLBP mRNA is present throughout the cell
cycle (43). The translation of SLBP mRNA is activated prior
to entering S phase, and SLBP is rapidly degraded at the end
of S phase (43), effectively restricting histone mRNA pro-
cessing to S phase (46). SLBP is cell cycle regulated and,
unlike histone mRNA, is not directly regulated by the inhi-
bition of DNA replication (42). Since SLBP is also required
for histone mRNA translation (32), the amount of SLBP
also limits the amount of active histone mRNA that can
accumulate in the cell.
While both histone gene transcription and the half-life of
histone mRNA are regulated during the cell cycle, the major
regulatory step is the processing of the 3 end of histone
mRNA (19, 24, 36). One aspect of this regulation is the cell
cycle regulation of SLBP. However, there is evidence that a
“heat-labile factor” required for histone pre-mRNA process-
ing is also involved in cell cycle regulation (14). The “heat-
labile factor” has recently been identified as symplekin, a com-
ponent of the cleavage complex for both histone pre-mRNA
processing (22) and polyadenylation (37). Since symplekin is
involved in both polyadenylation and histone 3 processing, it
is not clear how it might specifically regulate histone 3 pro-
cessing. There is also evidence that there may also be regula-
tion of the activity of U7 snRNP during the HeLa cell cycle
(20), although these results have not been reproduced (3).
This study identifies ZFP100 as a limiting factor for histone
pre-mRNA processing in vivo. We have also defined a critical
role for an active U7 snRNP containing ZFP100 not only in
histone mRNA metabolism but also, surprisingly, in the pro-
gression from G1 into S phase. ZFP100 is one of three known
U7 snRNP-specific proteins and was identified as a protein
that interacts with the SLBP/histone pre-mRNA complex (7).
The other U7-specific proteins, Lsm10 and Lsm11, are part of
the Sm complex bound to U7 snRNA (30, 31) and are likely to
be stable components of U7 snRNP in contrast to ZFP100,
which is bound to the U7 snRNP through a specific sequence
on the amino terminus of Lsm11 (31, 40). Thus, it is possible
that ZFP100 is a component of the “active” U7 snRNP and
need not be stably associated with the U7 snRNP. There are
many proteins in splicosomal snRNPs that are associated with
the active forms of the snRNPs but are not part of the purified
stable core snRNP (2, 16, 25). Consistent with the possibility
that ZFP100 is loosely associated with U7 snRNP is the ob-
servation that the purified U7 snRNP, which contains Lsm10
and Lsm11, does not contain ZFP100 (30, 31, 34).
The GFP-SL reporter mimics the expression of histone
mRNA and provides a rapid way to measure the expression of
a protein from an mRNA ending in the stem-loop. Expressing
two proteins, ZFP100 and SLBP, increased the expression of
GFP from the GFP-SL reporter three- to fourfold. Increasing
the amount of ZFP100 increases the level of the reporter
mRNA, which is consistent with its role in histone pre-mRNA
processing. In contrast, increasing the amount of SLBP has a
lesser effect on histone mRNA levels and likely stimulates
translation as well as processing and/or stability of the reporter
mRNA. Note that there was no increase in S-phase cells or in
the number of cells expressing the reporter (Fig. 3B), so the
increased ZFP100 concentration likely increases the efficiency
of processing the reporter mRNA in S-phase cells.
In contrast, the expression of other U7-specific snRNP pro-
teins, Lsm10 and/or Lsm11, had no effect on expression of the
reporter. In particular, the expression of Lsm10 and Lsm11
FIG. 7. Knockdown of Lsm10 or Lsm11 results in a G1 arrest of U2OS cells. (A) U2OS cells were transfected with a control siRNA (C2, lane
1), an siRNA against ZFP100 (Z2, lane 2), two siRNAs against Lsm11 (11-1 and 11-2, lanes 3 and 4), a mixture of the two (11-1/2, lane 5), or an
siRNA against SLBP (S2, lane 6). Lysates were prepared and analyzed by Western blotting for SLBP (bottom) and, as a loading control, CA150
(top). CA150; anti-CA150; SLBP; anti-SLBP. (B) Cell cycle analysis of U2OS cells transfected with siRNAs, C2, Z2, 11-1, 11-2, and a mixture
of 11-1 and 11-2 (11-1/2). The percentage of cells in each cell cycle phase is indicated. (C) U2OS cells transfected with a control siRNA (C2, lane
1), an siRNA against ZFP100 (Z2, lane 2), two siRNAs against Lsm10 (10-1 and 10-2, lanes 3 and 4), a mixture of the two (10-1/2, lane 5), or an
siRNA against SLBP (S2, lane 6). Lysates were prepared and analyzed by Western blotting for SLBP (bottom) and, as a loading control, CA150
(top). The two blots shown are two pieces of the same Western blot exposed at the same time. CA150; anti-CA150; SLBP; anti-SLBP. (D) Cell
cycle analysis of U2OS cells transfected with siRNAs, C2, Z2, 10-1, 10-2, and a mixture.
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together increased the overall amount of U7 snRNA two- to
threefold (Fig. 4B) without increasing the expression of the
GFP-SL reporter. The increase in U7 snRNA is likely due to
more-efficient assembly of the U7 snRNP, which normally is
only 20% efficient (18), likely as a result of limiting amounts of
the Lsm10/Lsm11 heterodimer required for U7 snRNP assem-
bly (1). In contrast, the expression of ZFP100 had no effect on
U7 snRNA levels but increased activity of the reporter four-
fold. Thus, the amount of ZFP100 (and likely the amount of
active U7 snRNP) is limiting for histone mRNA expression.
In addition to ZFP100 being a critical factor for histone
mRNA expression, surprisingly, an active U7 snRNP is critical
for cell cycle progression. Knocking down U7 snRNP compo-
nents, particularly ZFP100, results in cells arresting in G1. The
arrest is not caused by a failure to express sufficient histone
mRNA at the G1/S transition. This arrest is also not due to
simply a defect in histone mRNA metabolism, since the de-
pletion of SLBP results in slow progression through S phase
rather than an arrest in G1 phase (Fig. 5B) (38, 45) and S-
phase arrest is also observed when one interferes with chro-
matin assembly (44). The G1 arrest occurs early in G1 prior to
the point where the cell activates synthesis of SLBP and E2F1.
Part of the decision to initiate progression into S phase there-
fore requires that there be sufficient amounts of active U7
snRNP. We envision that the pool of active U7 snRNP during
the cell cycle is likely limited by the amount of active ZFP100
since the amount of U7 snRNA doesn’t vary during the cell
cycle (43). The arrest in G1 due to insufficient active U7 snRNP
may result from the cell “checking” its ability to synthesize
sufficient histone mRNA to successfully progress through S
phase. The molecular details that lead to this arrest are not
known but likely integrate into other signals that lead to the
decision of a cell to progress through G1 to enter S phase.
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